-
Company Profile
![]()
Ascopiave SpA – Company Profile
Ascopiave SpA (Ascopiave), a subsidiary of Asco Holding SpA, is a utility company that distributes natural gas. It also operates in other sectors related to its core business, such as co-generation and heat management. The company owns concessions and direct assignments for the management of distribution of gas across municipalities in Italy. Ascopiave owns stake in Estenergy, which markets electric power and natural gas in the regions of Friuli Venezia-Giulia, Lombardy and Veneto. It also operates in the water sector...
Add to Basket -
Product Insights
Computed Tomography (CT) Systems Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Computed Tomography Systems Pipeline Market Report Overview Computed Tomography (CT) is a powerful, non-destructive evaluation technique used for producing 2D and 3D cross-sectional images of an object from a flat X-ray image. It is used on patients with a high risk of colon cancer, or full-motion heart scans for patients with a high risk of heart disease. It can also be used to image complex fractures, detect infarction, tumors, calcifications, hemorrhage, bone trauma, and also acute and chronic changes in...
-
Product Insights
Bcl 2 Like Protein 1 (Apoptosis Regulator BclX or BCLX or BCL2L1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Bcl-2-like protein 1 is a potent inhibitor of cell death. The Bcl 2 Like Protein 1 (Apoptosis Regulator BclX or BCLX or BCL2L1) pipeline drugs market research report provides comprehensive information on the Bcl 2 Like Protein 1 (Apoptosis Regulator BclX or BCLX or BCL2L1) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also reviews key players involved in Bcl 2 Like Protein 1 (Apoptosis...
-
Product Insights
Barbers
Barbers is a 30MW onshore wind power project located in Catalonia, Spain. It was developed by Tarraco Eolica Asco SL. The project is currently active. The project is owned by Eolia Renovables de Inversiones SCR SA. Barbers profile includes core details such as plant name, technology, capacity, status, plant proponents (owners, developers etc.), owner stakes etc as well as key operational data including generation, year online, decommissioning year, capital expenditure etc. Details on project specific contacts along with relevant news,...
-
Product Insights
Anaplastic Astrocytoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Anaplastic astrocytoma is a grade III tumor. It accounts for two percent of all brain tumors. It is a type of glioma that develops from star-shaped glial cells (astrocytes), which support nerve cells. Anaplastic astrocytoma grows faster and more aggressively than grade II astrocytomas. The tumor cells are not uniform in appearance and invade neighboring tissue. The Anaplastic Astrocytoma pipeline drugs market research report provides comprehensive information on the therapeutics under development for Anaplastic Astrocytoma, complete with analysis by stage...
-
Product Insights
Chondrosarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Chondrosarcoma is a cancer whose tumor cells produce pure hyaline cartilage that results in abnormal bone and/or cartilage growth. Signs and symptoms include pain in the affected area that may worsen at night or during physical activity, swelling in the painful area, a lump or mass, enlargement of an existing growth, limping, difficulty moving the affected limb, and changes in urination. Treatment includes chemotherapy and radiation therapy. The Chondrosarcoma pipeline drugs market research report provides comprehensive information on the therapeutics...
-
Product Insights
Endometrial Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Endometrial Cancer - Drugs In Development, 2022, provides an overview of the Endometrial Cancer (Oncology) pipeline landscape. Endometrial cancer is cancer that starts in the endometrium, the lining of the uterus (womb). Endometrial cancer is the most common type of uterine cancer. Although the exact cause of endometrial cancer is unknown, increased levels of estrogen appear to play a role. Estrogen helps stimulate the buildup of the lining of the...
-
Product Insights
Cyclin Dependent Kinase 2 (p33 Protein Kinase or Cell Division Protein Kinase 2 or CDK2 or EC 2.7.11.22) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Cyclin-dependent kinase 2 is an enzyme encoded by the CDK2 gene. CDK2 is the catalytic subunit of the cyclin-dependent protein kinase complex which regulates progression through the cell cycle. The activity of CDK2 is especially critical during the G1 to S phase transition. The Cyclin Dependent Kinase 2 pipeline drugs market research report provides comprehensive information on the therapeutics under development for Cyclin Dependent Kinase 2, complete with analysis by stage of development, drug target, mechanism of action (MoA), route...
-
Product Insights
Pontine Glioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Pontine gliomas are highly aggressive and difficult-to-treat brain tumors found at the base of the brain. One of the most common types is diffuse intrinsic pontine glioma (DIPG). DIPG affects the pons portion of the brainstem, rendering nervous system function impossible. Symptoms include double vision, inability to close the eyelids completely, dropping one side of the face, and difficulty chewing and swallowing. The pontine glioma pipeline drugs market research report provides comprehensive information on the therapeutics under development for pontine...
-
Product Insights
20s Proteasome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
The 20s Proteasome pipeline drugs market research report outlays comprehensive information on the 20s Proteasome targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also reviews key players involved in 20s Proteasome targeted therapeutics development with respective active and dormant or discontinued projects.
-
Product Insights
Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Prostaglandin E2 receptor 4 (EP4) is a prostaglandin receptor encoded by the PTGER4 gene. The activity of the receptor is mediated by G proteins that stimulate adenylate cyclase. It has a relaxing effect on smooth muscle. It plays an important role in regulating renal hemodynamics, intestinal epithelial transport, adrenal aldosterone secretion, and uterine function. The Prostaglandin E2 receptor 4 (EP4) pipeline market research report provides comprehensive information on the therapeutics under development for Prostaglandin E2 receptor 4 (EP4), complete with...
-
Product Insights
Clinical Decision Support Systems Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
The Clinical Decision Support Systems pipeline market research report provides comprehensive information about the Clinical Decision Support Systems pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
-
Product Insights
Pheochromocytoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Pheochromocytoma is a rare, usually non-cancerous (benign) tumor that develops in cells in the center of an adrenal gland. Symptoms include high blood pressure, severe headache, tremors, shortness of breath, and constipation. The Pheochromocytoma pipeline drugs market research report provides comprehensive information on the therapeutics under development for Pheochromocytoma (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the...
-
Product Insights
Fallopian Tube Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Fallopian Tube Cancer symptoms may include abnormal vaginal bleeding, especially after menopause, abdominal pain or a feeling of pressure in the abdomen, abnormal vaginal discharge that is white, clear or pinkish and a pelvic mass at the time of diagnosis. The Fallopian Tube Cancer pipeline drugs market research report provides an analysis of the Fallopian Tube Cancer drugs by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide also covers the...
-
Product Insights
Hairy Cell Leukemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
 Hairy cell leukemia is a rare, slow-growing cancer of the blood in which bone marrow makes too many B cells (lymphocytes), a type of white blood cell that fights infection. Symptoms include fatigue, easy bruising, recurring infections, weakness and weight loss. Risk factors include exposure to radiation, chemicals and saw dust. Treatment includes surgery, chemotherapy and radiation therapy. The Hairy Cell Leukemia pipeline drugs market research report outlays comprehensive information on the Hairy Cell Leukemia targeted therapeutics, complete with analysis...
-
Product Insights
Human cytomegalovirus 65 kDa Phosphoprotein (PP65 or 65 kDa Matrix Phosphoprotein or Tegument Protein UL83 or UL83) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
65-kDa cytosolic phosoprotein (pp65) counteracts the host antiviral immune response when activated and phosphorylated and by preventing IRF3 from entering the nucleus. It participates in the transactivation of viral major immediate-early genes by the recruitment of host IFI16 to the promoter pf these genes. The Human cytomegalovirus 65 kDa Phosphoprotein pipeline market research report provides comprehensive information on the therapeutics under development for PP65, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration...
-
Product Insights
Heparanase (Endo Glucoronidase or Heparanase 1 or HPSE or EC 3.2.1.166) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Heparanase is preferentially expressed in human tumors and its over-expression in tumor cells. The enzyme also releases angiogenic factors from the ECM and thereby induces an angiogenic response. Heparanase exhibits also non-enzymatic activities, independent of its involvement in ECM degradation. The Heparanase pipeline drugs market research report provides an analysis of the Heparanase drugs by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide also covers the descriptive pharmacological action of...
-
Product Insights
High Mobility Group Protein B1 (High Mobility Group Protein 1 or High Mobility Group Protein Box 1 or HMGB1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
High mobility group box 1 protein (HMGB1) is secreted by immune cells like macrophages, monocytes, and dendritic cells through a leaderless secretory pathway. Activated macrophages and monocytes secrete HMGB1. The HMGB1 pipeline market research report provides comprehensive information on the HMGB1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, the...
-
Product Insights
Neutropenia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Neutropenia is an abnormally low count of neutrophils, a type of white blood cell that helps fight off infections, particularly those caused by bacteria and fungi. Signs and symptoms include fevers, frequent infections, mouth ulcers, gum infections, and dysuria. Key Targets Granulocyte Colony Stimulating Factor Receptor, Beta Lactamase, C5a Anaphylatoxin Chemotactic Receptor 1, Caspase 3, Caspase 8, Caspase 9, Ergosterol, Lanosterol 14 Alpha Demethylase, Penicillin Binding Protein 1B, Penicillin Binding Protein 1C, Penicillin Binding Protein 3, Retinoic Acid Receptor Alpha,...
-
Product Insights
Injectable Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Injectable drug delivery devices are defined as the administration of a drug into a patient’s blood through a delivery device. The injectable drug delivery pipeline market research report provides comprehensive information about the injectable drug delivery pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.